Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dobritz

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Annals of Vascular Surgery|September 12, 2008
WITHDRAWN: Immediate and mid-term results following hybrid procedures for the treatment of thoracoabdominal aneurysms (TAAA) and secondary expanding aortic dissections (SED)Oliver Wolf, P Heider, M Hanke, et al.
Oncology|December 2, 2005
Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinomaF Eckel, S von Delius, M Mayr, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 27, 2012
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumoursK Herrmann, M Erkan, M Dobritz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2013
A reliable risk score for stage IV esophagogastric cancerS Blank, F Lordick, M Dobritz, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Annals of Vascular Surgery|September 12, 2008
WITHDRAWN: Immediate and mid-term results following hybrid procedures for the treatment of thoracoabdominal aneurysms (TAAA) and secondary expanding aortic dissections (SED)Oliver Wolf, P Heider, M Hanke, et al.
Oncology|December 2, 2005
Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinomaF Eckel, S von Delius, M Mayr, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 27, 2012
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumoursK Herrmann, M Erkan, M Dobritz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2013
A reliable risk score for stage IV esophagogastric cancerS Blank, F Lordick, M Dobritz, et al.
Pageof 4